Photo of Margaret E. McLaughlin-Drubin,  PhD

Margaret E. McLaughlin-Drubin, PhD

Brigham And Women's Hospital

Brigham And Women's Hospital
Phone: (617) 525-4241
Fax: (617) 525-4251


mdrubin@rics.bwh.harvard.edu

Margaret E. McLaughlin-Drubin, PhD

Brigham And Women's Hospital

EDUCATIONAL TITLES

  • Instructor, Medicine, Harvard Medical School
  • Associate Virologist, Infectious Diseases, Brigham And Women's Hospital

DF/HCC PROGRAM AFFILIATION

Publications

Powered by Harvard Catalyst
  • McLaughlin-Drubin ME. Human Papillomaviruses and Non-melanoma Skin Cancer. Semin Oncol 2015; 42:284-290. PubMed
  • Xylas J, Varone A, Quinn KP, Pouli D, McLaughlin-Drubin ME, Thieu HT, Garcia-Moliner ML, House M, Hunter M, Munger K, Georgakoudi I. Noninvasive assessment of mitochondrial organization in three-dimensional tissues reveals changes associated with cancer development. Int J Cancer 2014. PubMed
  • Varone A, Xylas J, Quinn KP, Pouli D, Sridharan G, McLaughlin-Drubin ME, Alonzo C, Lee K, Münger K, Georgakoudi I. Endogenous Two-Photon Fluorescence Imaging Elucidates Metabolic Changes Related to Enhanced Glycolysis and Glutamine Consumption in Precancerous Epithelial Tissues. Cancer Res 2014. PubMed
  • Munger K, Gwin TK, McLaughlin-Drubin ME. p16 in HPV-associated cancers. 2013; 4:1864-5. PubMed
  • McLaughlin-Drubin ME, Park D, Munger K. Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. Proc Natl Acad Sci U S A 2013; 110:16175-80. PubMed
  • McLaughlin-Drubin ME, Meyers J, Munger K. Cancer associated human papillomaviruses. Curr Opin Virol 2012; 2:459-66. PubMed
  • Herfs M, Yamamoto Y, Laury A, Wang X, Nucci MR, McLaughlin-Drubin ME, Münger K, Feldman S, McKeon FD, Xian W, Crum CP. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A 2012; 109:10516-21. PubMed
  • McLaughlin-Drubin ME, Crum CP, Münger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci U S A 2011; 108:2130-5. PubMed
  • McLaughlin-Drubin ME, Münger K. Oncogenic activities of human papillomaviruses. Virus Res. 2009; 143:195-208. PubMed
  • McLaughlin-Drubin ME,Munger K. The human papillomavirus E7 oncoprotein. Virology 2008; 384:335-44. PubMed
  • Nguyen CL,McLaughlin-Drubin ME,Munger K. Delocalization of the microtubule motor Dynein from mitotic spindles by the human papillomavirus E7 oncoprotein is not sufficient for induction of multipolar mitoses. Cancer Res 2008; 68:8715-22. PubMed
  • McLaughlin-Drubin ME,Huh KW,Munger K. Human papillomavirus type 16 E7 oncoprotein associates with E2F6. J Virol 2008; 82:8695-705. PubMed
  • McLaughlin-Drubin M,Munger K. The human papillomavirus type 8 E2 gene encodes a transforming activity sufficient for skin tumor formation in transgenic mice. J Invest Dermatol 2008; 128:2142-4. PubMed
  • McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta 2008; 1782:127-50. PubMed
  • Levitt JM, Hunter M, Mujat C, McLaughlin-Drubin M, Münger K, Georgakoudi I. Diagnostic cellular organization features extracted from autofluorescence images. Opt Lett 2007; 32:3305-7. PubMed
  • Drubin DA, McLaughlin-Drubin ME, Clawson GA, Meyers C. A protease inhibitor specifically inhibits growth of HPV-infected keratinocytes. Mol Ther 2006; 13:1142-8. PubMed
  • McLaughlin-Drubin ME, Bromberg-White JL, Meyers C. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology 2005; 338:61-8. PubMed
  • McLaughlin-Drubin ME, Meyers C. Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol. Med. 2005; 119:171-86. PubMed
  • McLaughlin-Drubin ME, Christensen ND, Meyers C. Propagation, infection, and neutralization of authentic HPV16 virus. Virology 2004; 322:213-9. PubMed
  • McLaughlin-Drubin ME, Meyers C. Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology 2004; 321:173-80. PubMed
  • McLaughlin-Drubin ME, Wilson S, Mullikin B, Suzich J, Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology 2003; 312:1-7. PubMed
  • Sen E, McLaughlin-Drubin M, Meyers C. Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication. Anticancer Res 2005; 25:1091-100. PubMed
  • Alam S, Bromberg-White J, McLaughlin-Drubin M, Sen E, Bodily JM, Meyers C. Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium. Anticancer Res 2005; 25:765-77. PubMed
Hide